Skip to content
HowShorted

Aligos Therapeutics, Inc. short interest in 2024

In 2024, Aligos Therapeutics, Inc.'s disclosed short interest ran from 1.12% of shares outstanding on 12 Jan 2024 to 16.65% on 31 Dec 2024, a change of +15.53 percentage points. The year's high was 16.65% on 31 Dec 2024 and its low 0.48% on 15 Mar 2024, averaging 4.43% across 16 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.97 days on 14 Jun 2024. Full history: Aligos Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Aligos Therapeutics, Inc. in 2024

2024 in figures

Start of year
1.12% (12 Jan 2024)
End of year
16.65% (31 Dec 2024)
Change
+15.53 pp
High
16.65% (31 Dec 2024)
Low
0.48% (15 Mar 2024)
Average
4.43%
Highest days to cover
7.97 (14 Jun 2024)
SEC filings marked
8

Every report in 2024

Aligos Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20241.12%4.51
31 Jan 20241.19%4.68
29 Feb 20240.49%1.00
15 Mar 20240.48%1.0010-K filed, results (8-K)
28 Mar 20241.15%2.48
15 Apr 20240.87%1.85
30 Apr 20241.11%3.71
15 May 20241.41%6.4810-Q filed, results (8-K)
31 May 20242.38%6.75
14 Jun 20242.37%7.97
28 Jun 20242.76%2.93
15 Aug 202410.17%1.0010-Q filed, results (8-K)
15 Nov 20248.12%1.0010-Q filed, results (8-K)
29 Nov 20247.91%1.00
13 Dec 202412.74%1.10
31 Dec 202416.65%1.23

See also: Aligos Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.